Section Arrow
IRMD.NASDAQ
- iRadimed Corp
Quotes are at least 15-min delayed:2026/03/12 02:21 EDT
Regular Hours
Last
 100.81
+1.865 (+1.88%)
Day High 
100.81 
Prev. Close
98.945 
1-M High
107.55 
Volume 
91.08K 
Bid
49.3
Ask
102
Day Low
97.7 
Open
98.11 
1-M Low
96 
Market Cap 
1.26B 
Currency 美元 
P/E 59.97 
%Yield 1.2 
10-SMA 101.75 
20-SMA 101.6 
50-SMA 99.96 
52-W High 107.9 
52-W Low 47.4775 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.65/2.32
Enterprise Value
1.26B
Balance Sheet
Book Value Per Share
7.44
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
73.24M
Operating Revenue Per Share
4.95
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
MDTMedtronic plc88.97-0.92-1.02%25.14PE
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.